Literature DB >> 12050235

Frequent occurrence of an intron 4 mutation in multiple endocrine neoplasia type 1.

Jeremy J O Turner1, Poloko D Leotlela, Anna A J Pannett, Simon A Forbes, J H Duncan Bassett, Brian Harding, Paul T Christie, David Bowen-Jones, Sian Ellard, Andrew Hattersley, Charles E Jackson, Richard Pope, Oliver W Quarrell, Richard Trembath, Rajesh V Thakker.   

Abstract

MEN1 is an autosomal dominant disorder characterized by parathyroid, pituitary, and pancreatic tumors. The MEN1 gene is located on chromosome 11q13 and encodes a 610-amino acid protein. MEN1 mutations are of diverse types and are scattered throughout the coding region, such that almost every MEN1 family will have its individual mutation. To further characterize such mutations we ascertained 34 unrelated MEN1 probands and undertook DNA sequence analysis. This identified 17 different mutations in 24 probands (2 nonsense, 2 missense, 2 in-frame deletions, 5 frameshift deletions, 1 frameshift deletional-insertion, 3 frameshift insertions, 1 donor splice site mutation, and a g-->a transition that resulted in a novel acceptor splice site in intron 4). The intron 4 mutation was found in 7 unrelated families, and the tumors in these families varied considerably, indicating a lack of genotype-phenotype correlation. However, this intron 4 mutation is the most frequently occurring germline MEN1 mutation ( approximately 10% of all mutations), and together with 5 others at codons 83-84, 118-119, 209-211, 418, and 516, accounts for 36.6% of all mutations, a finding that indicates an approach for identifying the widely diverse MEN1 mutations.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12050235     DOI: 10.1210/jcem.87.6.8607

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  13 in total

1.  Analysis of genotype-phenotype correlations and survival outcomes in patients with primary hyperparathyroidism caused by multiple endocrine neoplasia type 1: the experience at a single institution.

Authors:  Kiyomi Horiuchi; Takahiro Okamoto; Masatoshi Iihara; Toshihiko Tsukada
Journal:  Surg Today       Date:  2012-10-09       Impact factor: 2.549

2.  Multiple endocrine neoplasia syndrome type 1: institution, management, and data analysis of a nationwide multicenter patient database.

Authors:  Francesca Giusti; Luisella Cianferotti; Francesca Boaretto; Filomena Cetani; Federica Cioppi; Annamaria Colao; Maria Vittoria Davì; Antongiulio Faggiano; Giuseppe Fanciulli; Piero Ferolla; Diego Ferone; Caterina Fossi; Francesco Giudici; Giorgio Gronchi; Paola Loli; Franco Mantero; Claudio Marcocci; Francesca Marini; Laura Masi; Giuseppe Opocher; Paolo Beck-Peccoz; Luca Persani; Alfredo Scillitani; Giovanna Sciortino; Anna Spada; Paola Tomassetti; Francesco Tonelli; Maria Luisa Brandi
Journal:  Endocrine       Date:  2017-01-28       Impact factor: 3.633

3.  A novel intronic mutation and a missense mutation of MEN1 identified in two Chinese families with multiple endocrine neoplasia type 1.

Authors:  B Han; Z Y Song; J J Wu; W Liu; B L Liu; X P Ye; X Chen; C M Pan; H Y Xu; L Li; H Zhu; Y L Lu; W L Wu; M D Chen; H D Song; J Qiao
Journal:  J Endocrinol Invest       Date:  2012-04-05       Impact factor: 4.256

Review 4.  Care for patients with multiple endocrine neoplasia type 1: the current evidence base.

Authors:  C R C Pieterman; M R Vriens; K M A Dreijerink; R B van der Luijt; G D Valk
Journal:  Fam Cancer       Date:  2011-03       Impact factor: 2.375

5.  Two novel mutations in the MEN1 gene in subjects with multiple endocrine neoplasia-1.

Authors:  M Ozturk; C Y Chiu; N Akdeniz; S F Jenq; S C Chang; C Y Hsa; T S Jap
Journal:  J Endocrinol Invest       Date:  2006-06       Impact factor: 4.256

6.  Analysis of 55 patients with multiple endocrine neoplasia type 1-associated insulinoma from a single center in China.

Authors:  Yuan Zhao; Jie Yu; Yiwen Liu; Lu Lyu; Fan Ping; Lingling Xu; Wei Li; Ou Wang; Qiang Xu; Wenming Wu; Huabing Zhang; Yuxiu Li
Journal:  Orphanet J Rare Dis       Date:  2022-06-13       Impact factor: 4.303

Review 7.  MEN1, MEN4, and Carney Complex: Pathology and Molecular Genetics.

Authors:  Marie Helene Schernthaner-Reiter; Giampaolo Trivellin; Constantine A Stratakis
Journal:  Neuroendocrinology       Date:  2015-01-09       Impact factor: 4.914

8.  Treatment-resistant pediatric giant prolactinoma and multiple endocrine neoplasia type 1.

Authors:  Hoong-Wei Gan; Chloe Bulwer; Owase Jeelani; Michael Alan Levine; Márta Korbonits; Helen Alexandra Spoudeas
Journal:  Int J Pediatr Endocrinol       Date:  2015-07-15

9.  Two nonsense somatic mutations in MEN1 identified in sporadic insulinomas.

Authors:  Cheng Qi; Jiayue Duan; Qingfeng Shi; Mingguang Wang; Changqing Yan
Journal:  FEBS Open Bio       Date:  2018-01-02       Impact factor: 2.693

Review 10.  Variable clinical expression in patients with a germline MEN1 disease gene mutation: clues to a genotype-phenotype correlation.

Authors:  Cornelis J Lips; Koen M Dreijerink; Jo W Höppener
Journal:  Clinics (Sao Paulo)       Date:  2012       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.